Home » Topics » Disease categories and therapies » Urology

Urology
RSS

NDA filed in U.S. for once-daily Xatral

Jan. 25, 2001

Binding and functional activity of the first truly selective alpha1A antagonist characterized

Jan. 24, 2001

Potential new therapy for erectile dysfunction presented by Dong-A

Jan. 22, 2001

YM-905 enters late-stage clinical development overseas

Jan. 19, 2001

Acute and chronic antidiuretic effects of OPC-51803, a nonpeptide V2 receptor agonist

Jan. 11, 2001

Rho kinase antagonism as a therapeutic alternative for erectile dysfunction

Jan. 4, 2001

Once-daily Detrol approved by FDA for treatment of overactive bladder

Dec. 27, 2000

Taisho presents new compounds with potential in the treatment of renal and cardiovascular conditions

Dec. 22, 2000

Vivus granted third PDE inhibitor patent

Dec. 21, 2000

Cialis shows promise as ED therapy in phase II

Dec. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...